Xolair® has a simple dosing
schedule1
Administered subcutaneously using a pre-filled syringe*
The approved dose of Xolair® is 2 x 150 mg injections. Patients should be observed following injection1
Xolair® should be administered by a healthcare professional every 4 weeks1
Prescribers are advised to regularly check the need to continue treatment**1
Well established safety profile and more than 819,419 patient-years experience***1–3
Prescribing Xolair® in CSU, there is:
No need to determine baseline lgE
levels
No need to calculate the dose based on patient's body weight